# FDA Inspection 804024 - Shire Pharmaceuticals, LLC - September 28, 2012

Source: https://www.keypedia.com/records/fda_inspections/shire-pharmaceuticals-llc/d780e8b1-5a58-4ab6-94b7-ecbcca5279b7
Source feed: FDA_Inspections

> FDA Inspection 804024 for Shire Pharmaceuticals, LLC on September 28, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 804024
- Company Name: Shire Pharmaceuticals, LLC
- Inspection Date: 2012-09-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 657279 - 2010-04-23](https://www.keypedia.com/records/fda_inspections/shire-pharmaceuticals-llc/f0c81573-db10-41db-a3dd-65035fa4c39d)
- [FDA Inspection 657279 - 2010-04-23](https://www.keypedia.com/records/fda_inspections/shire-pharmaceuticals-llc/15e56297-9846-4b95-997e-a2280a414b0a)

Company: https://www.keypedia.com/companies/shire-pharmaceuticals-llc/60b5bbc8-7838-423e-ad9a-5d05a666caa2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c